BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
24203 results:

  • 1. cancer treatment Before and After Physician-Pharmacy Integration.
    Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
    JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
    Adames A; O'Brien DR; Kelly AR; Saltz LB; Garcia-Aguilar J; Zinovoy M; Williams V; Wu A; Reyngold M; Hajj C; Crane C; Cercek A; Smith JJ; Markova A; Cuaron J; McCann P; Romesser PB
    Int J Colorectal Dis; 2024 May; 39(1):75. PubMed ID: 38780794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Epidemiological characteristics of early-onset colorectal cancer: a prospective cohort study from a single center].
    Jin T; Zhu YS; Liu CC; Xu X; Lu W; Xiao Q; Ding KF; Zheng S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):457-463. PubMed ID: 38778685
    [No Abstract]    [Full Text] [Related]  

  • 4. The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: A systematic review and meta-analysis.
    Wibowo AA; Willyanto NA
    Clin Nutr ESPEN; 2024 Jun; 61():322-332. PubMed ID: 38777451
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel perineal exposure method in laparoscopic abdominal perineal resection of rectal cancer: a case series study.
    Ma J; Tang D; Tang Y; Wang D; Jiang P; Zhang Y
    BMC Surg; 2024 May; 24(1):163. PubMed ID: 38769559
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
    Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
    Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
    Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
    Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Value of Real-World Evidence for treatment Selection: A Case Study in Colon cancer.
    Shen L; van Gestel A; Prinsen P; Vink G; van Erning FN; Geleijnse G; Kaptein M
    JCO Clin Cancer Inform; 2024 May; 8():e2300186. PubMed ID: 38753347
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.
    Huang KC; Chiang SF; Chang HY; Hong WZ; Chen JY; Lee PC; Liang JA; Ke TW; Peng SL; Shiau AC; Chen TW; Yang PC; Chen WT; Chao KSC
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38749537
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Examining variations in body composition among patients with colorectal cancer according to site and disease stage.
    da Silva Nascimento ML; Alves Bennemann N; de Sousa IM; de Oliveira Bezerra MR; Villaça Chaves G; Moreira Lima Verde SM; Fernandes Maurício S; Barreto Campello Carvalheira J; Santos Mendes MC; Miranda AL; da Costa Pereira JP; Gonzalez MC; Prado CM; Fayh APT
    Sci Rep; 2024 May; 14(1):10829. PubMed ID: 38734789
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of risk characteristics for early progression and late progression in locally advanced rectal cancer patients: a large population-based and validated study.
    Yu Y; Wu H; Qiu J; Wu S; Gan Y; Shao L; Lin C; Hong L; Wu J
    Support Care Cancer; 2024 May; 32(6):340. PubMed ID: 38733415
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Distinct Driver Pathway Enrichments and a High Prevalence of
    Tapia-Valladares C; Valenzuela G; González E; Maureira I; Toro J; Freire M; Sepúlveda-Hermosilla G; Ampuero D; Blanco A; Gallegos I; Morales F; Erices JI; Barajas O; Ahumada M; Contreras HR; González J; Armisén R; Marcelain K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731914
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in Gastric cancer Cells.
    Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy of surgical treatment of perianal infection in patients with hematological malignancy.
    He J; Ni Z; Li Z
    Medicine (Baltimore); 2024 May; 103(19):e38082. PubMed ID: 38728504
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
    Wang DS; Ren C; Li SS; Fong WP; Wu XJ; Xiao J; Li BK; Zheng Y; Ding PR; Chen G; Qiu MZ; Wang ZQ; Wang FH; Luo HY; Wang F; Wang XZ; Wang LY; Xie DJ; Chen T; Li LR; Lu ZH; Zhai XH; Liu TS; Yuan Y; Chen JQ; Tan Q; Pan ZZ; Wan DS; Zhang R; Yuan YF; Xu RH; Li YH
    PLoS Med; 2024 May; 21(5):e1004389. PubMed ID: 38728364
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Robotic versus laparoscopic anterior resection for the treatment of stage II and III sigmoid colon cancer: a propensity score-matched analysis.
    Wang J; Zhou J; Zhao S; Li R; Fu Y; Sun L; Wang W; Wang L; Wang D
    J Robot Surg; 2024 May; 18(1):207. PubMed ID: 38727774
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
    Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
    J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Preoperative three-dimensional lung volumetry predicts respiratory complications in patients undergoing major liver resection for colorectal metastases.
    Elmaagacli S; Thiele C; Meister F; Menne P; Truhn D; Olde Damink SWM; Bickenbach J; Neumann U; Lang SA; Vondran F; Amygdalos I
    Sci Rep; 2024 May; 14(1):10594. PubMed ID: 38719953
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer.
    Fan Y; Ye J; Kang Y; Niu G; Shi J; Yuan X; Li R; Han J; Ji X
    Sci Adv; 2024 May; 10(19):eadm9561. PubMed ID: 38718119
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1211.